| Size | Price | |
|---|---|---|
| Other Sizes |
| Toxicity/Toxicokinetics |
Toxicity Summary
Identification and Uses: 1,3-Propanediol (PDO) is a colorless to pale yellow, high-viscosity liquid. It is primarily used in the production of polypropylene terephthalate (PTT) polymers, which are used in fibers and fabrics such as textiles, engineering thermoplastics, and monofilaments. PDO is also used in cosmetics and personal care products, engine coolants, and as a solvent for inkjet and screen printing inks. Human Exposure and Toxicity: In a reported case study, the body of a 45-year-old woman was found with a suicide note and two antifreeze containers. Analysis of bodily fluids collected from the deceased revealed an ethanol content of 58 mg/dL, but no suspected ethylene glycol was detected in the samples. However, an unusually high peak for the internal standard PDO was found in the samples. Gas chromatography-mass spectrometry confirmed the presence of PDO at a concentration of 445 mg/dL. Animal Studies: This study aimed to determine the potential effects of repeated inhalation of PDO in rats. Rats were exposed to PDO vapor or vapor/aerosol mixtures at concentrations of 0, 41, 650, or 1800 mg/m³ for 6 hours a day, 5 days a week, for 2 weeks (9 exposures in total). In vivo responses were observed or measured daily. No abnormal external responses were observed, and no deaths occurred. Clinicopathological (blood cell counts, serum chemistry parameters) and histopathological (gross pathology, organ weight, and histopathology) findings in the exposed rats were similar to those in the unexposed control group. The highest tested concentration of 1800 mg/m³ (the highest achievable concentration) in this study was determined as the no-observed effect level (NOEL). Inhalation of PDO vapor or vapor/aerosol mixtures did not appear to cause significant harm. PDO, with or without activation, was non-mutagenic to Salmonella Typhimurium strains TA1535, TA1537, TA98, TA100, and TA102. PDO was also non-mutagenic in the in vivo mouse micronucleus assay. Furthermore, PDO had a negative effect on inducing structural and numerical abnormalities in Chinese hamster V79 cells, with or without metabolic activation. Non-Human Toxicity Values Oral LD50 in rats: 15 g/kg; Dermal LD50 in rabbits: > 20 g/kg; Oral LD50 in mice: 4773 mg/kg |
|---|---|
| References |
|
| Additional Infomation |
Propane-1,3-diol is the simplest member of the propane-1,3-diol family. Its structure is a propane molecule, with each methyl group having a hydrogen atom replaced by a hydroxyl group. It is a colorless, viscous, water-soluble liquid with a boiling point as high as 210°C. It can be used in the synthesis of certain polymers and is also used as a solvent and antifreeze. It is both a proton solvent and a metabolite. 1,3-Propanediol has been reported to be present in Arabidopsis thaliana, tomato (Solanum lycopersicum), and grape (Vitis vinifera), and relevant data exist. 1,3-Propanediol is a metabolite found or produced in Saccharomyces cerevisiae. See also: Propanediol (note moved here).
|
| Molecular Formula |
C3H8O2
|
|---|---|
| Molecular Weight |
76.09
|
| Exact Mass |
76.052
|
| CAS # |
504-63-2
|
| Related CAS # |
1,3-Propanediol-d6;284474-77-7;1,3-Propanediol-d8;285978-25-8;1,3-Propanediol-d2;38645-14-6
|
| PubChem CID |
10442
|
| Appearance |
Colorless to light yellow liquid
|
| Density |
1.052
|
| Boiling Point |
214.4±0.0 °C at 760 mmHg
|
| Melting Point |
-32 °C
|
| Flash Point |
79.4±0.0 °C
|
| Vapour Pressure |
0.0±0.9 mmHg at 25°C
|
| Index of Refraction |
1.434
|
| LogP |
-1.04
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
2
|
| Rotatable Bond Count |
2
|
| Heavy Atom Count |
5
|
| Complexity |
12.4
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
C(CO)CO
|
| InChi Key |
YPFDHNVEDLHUCE-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C3H8O2/c4-2-1-3-5/h4-5H,1-3H2
|
| Chemical Name |
propane-1,3-diol
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: 100 mg/mL (1314.23 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (32.86 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (32.86 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (32.86 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 13.1423 mL | 65.7117 mL | 131.4233 mL | |
| 5 mM | 2.6285 mL | 13.1423 mL | 26.2847 mL | |
| 10 mM | 1.3142 mL | 6.5712 mL | 13.1423 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Link: https://clinicaltrials.gov/ct2/show/NCT05351398
Conditions:Advanced Gastric Carcinoma